Intravesical prostatic protrusion predicts clinical progression of benign prostatic enlargement in patients receiving medical treatment: Original Article: Clinical Investigations

International Journal of Urology

Volumn 17, Issue 1, 2010, Pages 69-74

  Lee, Lui Shiong ^a   Sim, Hong Gee ^a   Lim, Kok Bin ^a   Wang, Delin ^b   Foo, Keong Tatt ^a  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

^b CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Benign prostatic hyperplasia; Disease progression; Prostatic adenoma; Prostatic diseases; Ultrasonography

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; PROSTATE SPECIFIC ANTIGEN; STEROID 5ALPHA REDUCTASE INHIBITOR;

ADULT; AGED; ARTICLE; DISEASE COURSE; HUMAN; INTERNATIONAL PROSTATE SYMPTOM SCORE; LOWER URINARY TRACT SYMPTOM; MAJOR CLINICAL STUDY; MALE; OUTPATIENT DEPARTMENT; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; RESIDUAL URINE; URINE RETENTION; UROFLOWMETRY; WATCHFUL WAITING;

AGED; AGED, 80 AND OVER; DISEASE PROGRESSION; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PROSTATIC HYPERPLASIA; RETROSPECTIVE STUDIES; URINARY BLADDER;

EID: 74049112244     PISSN: 09198172     EISSN: 14422042     Source Type: Journal    
DOI: 10.1111/j.1442-2042.2009.02409.x     Document Type: Article

References (18)

1. Chute CG, Panser LA, Girman CJ et al. The prevalence of prostatism: a population-based survey of urinary symptoms. J. Urol. 1993 150 : 85 9.
2. Li MK, Lester G, Patron N et al. An Asian multinational prospective observational registry of patients with benign prostatic hyperplasia, with a focus on comorbidities, lower urinary tract symptoms and sexual function. BJU Int. 2007 101 : 197 202.
3. Jacobsen SJ, Jacobsen DJ, Girman CJ et al. Natural history of prostatism: risk factors for acute urinary retention. J. Urol. 1997 152 : 481 487.
4. Roehrborn CG, McConnell JD, Lieber M et al. Serum prostate-specific antigen concentration is a powerful predictor of acute urinary retention and need for surgery in men with clinical benign prostatic hyperplasia. PLESS Study Group. Urology 1999 53 : 473 480.
5. Porru D, Jalious H, Cvalli V, Sallusto F, Rovereto B. Prognostic value of a combination of IPSS, flow rate and residual urine volume compared to pressure-flow studies in the pre-operative evaluation of symptomatic BPH. Eur. Urol. 2002 41 : 246 249.
6. Chia SJ, Heng CT, Chan SP, Foo KT. Correlation of intravesical prostatic protrusion with bladder outlet obstruction. BJU Int. 2003 91 : 371 374.
7. Nose H, Foo KT, Lim KB, Yokoyama T, Ozawa H, Kumon H. Accuracy of two noninvasive methods of diagnosing bladder outlet obstruction using ultrasonography: intravesical prostatic protrusion and velocity-flow video urodynamics. Urology 2005 65 : 493 497.
8. Tan YH, Foo KT. Intravesical prostatic protrusion predicts the outcome of a trial without catheter following acute urine retention. J. Urol. 2003 170 : 2339 2341.
9. Mariappan P, Brown D, McNeil A. Intravesical prostatic protrusion is better than prostate volume in predicting outcome of trial without catheter in white men presenting with acute urinary retention: a prospective clinical study. J. Urol. 2007 178 : 573 577.
10. Yuen JSP, Tan JKN, Cheng CWS, Foo KT. Effects of bladder volume on trans-abdominal ultrasound measurements of intravesical prostatic protrusion and volume. Int. J. Urol. 2002 9 : 225 229.
11. Foo KT, Chia SJ, David C et al. Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia. Ministry of Health, Singapore, 2005.
12. Randalls A. Surgical Pathology of Prostatic Obstruction. Williams & Wilkins, Baltimore, 1931.
13. Lim KB, Ho H, Foo KT, Wong MY, Fook-Chong S. Comparison of intravesical prostatic protrusion, prostate volume and serum prostatic specific antigen in the evaluation of bladder outlet obstruction. Int. J. Urol. 2006 13 : 1509 1513.
14. Ochiai A, Kojima M. Correlation of ultrasound estimated bladder weight with ultrasound appearance of the prostate and postvoid residual urine in men with lower urinary tract symptoms. Urology 1998 51 : 722 729.
15. Vesely S, Kuntson T, Damber JE, Dicuio M, Dahlstrnad C. Relationship between age, prostate volume, prostate specific antigen,symptom score and uroflowmetry in men with lower urinary tract symptoms. Scand. J. Urol. Nephrol. 2003 36 : 322 328.
16. Barry MJ, Williford WO, Chang Y et al. Benign prostatic hyperplasia specific health status measures in clinical research: how much change in the American Urological Association symptom index and the benign prostatic hyperplasia impact index is perceptible to patients? J. Urol. 1995 154 : 1770 1774.
17. Bosch JL, Hop WC, Kirkels WJ, Schroder FH. The International Prostate Symptom Score in a community-based sample of men between 55 and 74 years of age: prevalence and correlation of symptoms with age, prostate volume, flow rate and residual urine volume. Br. J. Urol. 1995 75 : 622 630.
18. McConnell J, Roehrborn CG, Bautista O et al. The long-term effect of doxazosin, finasteride, and combination therapy on clinical progression of benign prostatic hyperplasia. N. Engl. J. Med. 2003 349 : 2387 2389.